Association of annexin A2 with cancer development (Review)
- Authors:
- Xiao-Heng Xu
- Wei Pan
- Li-Hua Kang
- Hui Feng
- Yan-Qiu Song
-
Affiliations: Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, P.R. China, Department of Pediatrics, The Second Hospital of Jilin University, Changchun, Jilin, P.R. China - Published online on: March 5, 2015 https://doi.org/10.3892/or.2015.3837
- Pages: 2121-2128
This article is mentioned in:
Abstract
 |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bao H, Jiang M, Zhu M, Sheng F, Ruan J and Ruan C: Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol. 90:177–185. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma MC and Sharma M: The role of annexin II in angiogenesis and tumor progression: A potential therapeutic target. Curr Pharm Des. 13:3568–3575. 2007. View Article : Google Scholar | |
|
Lokman NA, Ween MP, Oehler MK and Ricciardelli C: The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 4:199–208. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gerke V and Moss SE: Annexins: From structure to function. Physiol Rev. 82:331–371. 2002.PubMed/NCBI | |
|
Rescher U and Gerke V: Annexins - unique membrane binding proteins with diverse functions. J Cell Sci. 117:2631–2639. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hajjar KA, Guevara CA, Lev E, Dowling K and Chacko J: Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2. J Biol Chem. 271:21652–21659. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Mai J, Finley RL Jr, Waisman DM and Sloane BF: Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J Biol Chem. 275:12806–12812. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Madureira PA, Surette AP, Phipps KD, Taboski MA, Miller VA and Waisman DM: The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood. 118:4789–4797. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hajjar KA, Jacovina AT and Chacko J: An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem. 269:21191–21197. 1994.PubMed/NCBI | |
|
Courtneidge S, Ralston R, Alitalo K and Bishop JM: Subcellular location of an abundant substrate (p36) for tyrosine-specific protein kinases. Mol Cell Biol. 3:340–350. 1983.PubMed/NCBI | |
|
Eberhard DA, Karns LR, VandenBerg SR and Creutz CE: Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding. J Cell Sci. 114:3155–3166. 2001.PubMed/NCBI | |
|
Burger A, Berendes R, Liemann S, et al: The crystal structure and ion channel activity of human annexin II, a peripheral membrane protein. J Mol Biol. 257:839–847. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Camors E, Monceau V and Charlemagne D: Annexins and Ca2+ handling in the heart. Cardiovasc Res. 65:793–802. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jost M, Thiel C, Weber K and Gerke V: Mapping of three unique Ca2+-binding sites in human annexin II. Eur J Biochem. 207:923–930. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Jost M, Weber K and Gerke V: Annexin II contains two types of Ca2+-binding sites. Biochem J. 298:553–559. 1994. | |
|
Filipenko NR, Kang HM and Waisman DM: Characterization of the Ca2+-binding sites of annexin II tetramer. J Biol Chem. 275:38877–38884. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Filipenko NR and Waisman DM: The C terminus of annexin II mediates binding to F-actin. J Biol Chem. 276:5310–5315. 2001. View Article : Google Scholar | |
|
Hayes MJ, Shao D, Bailly M and Moss SE: Regulation of actin dynamics by annexin 2. EMBO J. 25:1816–1826. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jones PG, Moore GJ and Waisman DM: A nonapeptide to the putative F-actin binding site of annexin-II tetramer inhibits its calcium-dependent activation of actin filament bundling. J Biol Chem. 267:13993–13997. 1992.PubMed/NCBI | |
|
Rescher U, Ruhe D, Ludwig C, Zobiack N and Gerke V: Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate binding protein recruited to actin assembly sites at cellular membranes. J Cell Sci. 117:3473–3480. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Su M, Shi JJ, Yang YP, Li J, Zhang YL, Chen J, Hu LF and Liu CF: HDAC6 regulates aggresome-autophagy degradation pathway of α-synuclein in response to MPP+-induced stress. J Neurochem. 117:112–120. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Aukrust I, Hollås H, Strand E, Evensen L, Travé G, Flatmark T and Vedeler A: The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV. J Mol Biol. 368:1367–1378. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kassam G, Manro A, Braat CE, Louie P, Fitzpatrick SL and Waisman DM: Characterization of the heparin binding properties of annexin II tetramer. J Biol Chem. 272:15093–15100. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Vedeler A and Hollås H: Annexin II is associated with mRNAs which may constitute a distinct subpopulation. Biochem J. 348:565–572. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Gould KL, Woodgett JR, Isacke CM and Hunter T: The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol. 6:2738–2744. 1986.PubMed/NCBI | |
|
Jost M and Gerke V: Mapping of a regulatory important site for protein kinase C phosphorylation in the N-terminal domain of annexin II. Biochim Biophys Acta. 1313:283–289. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Glenney JR Jr and Tack BF: Amino-terminal sequence of p36 and associated p10: Identification of the site of tyrosine phosphorylation and homology with S-100. Proc Natl Acad Sci USA. 82:7884–7888. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Luo W, Yan G, Li L, et al: Epstein-Barr virus latent membrane protein 1 mediates serine 25 phosphorylation and nuclear entry of annexin A2 via PI-PLC-PKCalpha/PKCbeta pathway. Mol Carcinog. 47:934–946. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
de Graauw M, Tijdens I, Smeets MB, Hensbergen PJ, Deelder AM and van de Water B: Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin activation. Mol Cell Biol. 28:1029–1040. 2008. View Article : Google Scholar : | |
|
Morel E and Gruenberg J: Annexin A2 binding to endosomes and functions in endosomal transport are regulated by tyrosine 23 phosphorylation. J Biol Chem. 284:1604–1611. 2009. View Article : Google Scholar | |
|
Hubaishy I, Jones PG, Bjorge J, Bellagamba C, Fitzpatrick S, Fujita DJ and Waisman DM: Modulation of annexin II tetramer by tyrosine phosphorylation. Biochemistry. 34:14527–14534. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Regnouf F, Sagot I, Delouche B, Devilliers G, Cartaud J, Henry JP and Pradel LA: ‘In vitro’ phosphorylation of annexin 2 heterotetramer by protein kinase C. Comparative properties of the unphosphorylated and phosphorylated annexin 2 on the aggregation and fusion of chromaffin granule membranes. J Biol Chem. 270:27143–27150. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Johnstone SA, Hubaishy I and Waisman DM: Phosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein. J Biol Chem. 267:25976–25981. 1992.PubMed/NCBI | |
|
Deora AB, Kreitzer G, Jacovina AT and Hajjar KA: An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem. 279:43411–43418. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng L, Foley K, Huang L, et al: Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One. 6:e193902011. View Article : Google Scholar : PubMed/NCBI | |
|
Yan G, Luo W, Lu Z, Luo X, Li L, Liu S, Liu Y, Tang M, Dong Z and Cao Y: Epstein-Barr virus latent membrane protein 1 mediates phosphorylation and nuclear translocation of annexin A2 by activating PKC pathway. Cell Signal. 19:341–348. 2007. View Article : Google Scholar | |
|
Liu J, Rothermund CA, Ayala-Sanmartin J and Vishwanatha JK: Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleocytoplasmic shuttling of annexin II. BMC Biochem. 4:102003. View Article : Google Scholar | |
|
Madureira PA, Hill R, Miller VA, Giacomantonio C, Lee PW and Waisman DM: Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. Oncotarget. 2:1075–1093. 2011.PubMed/NCBI | |
|
Johnsson N, Marriott G and Weber K: p36, the major cytoplasmic substrate of src tyrosine protein kinase, binds to its p11 regulatory subunit via a short amino-terminal amphiphatic helix. EMBO J. 7:2435–2442. 1988.PubMed/NCBI | |
|
Réty S, Sopkova J, Renouard M, Osterloh D, Gerke V, Tabaries S, Russo-Marie F and Lewit-Bentley A: The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat Struct Biol. 6:89–95. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Waisman DM: Annexin II tetramer: Structure and function. Mol Cell Biochem. 149–150:301–322. 1995. View Article : Google Scholar | |
|
Kassam G, Choi KS, Ghuman J, Kang HM, Fitzpatrick SL, Zackson T, Zackson S, Toba M, Shinomiya A and Waisman DM: The role of annexin II tetramer in the activation of plasminogen. J Biol Chem. 273:4790–4799. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Cesarman GM, Guevara CA and Hajjar KA: An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem. 269:21198–21203. 1994.PubMed/NCBI | |
|
Hajjar KA and Krishnan S: Annexin II: A mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med. 9:128–138. 1999. View Article : Google Scholar | |
|
Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, Marcus AJ, Smith JD and Hajjar KA: Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest. 119:3384–3394. 2009.PubMed/NCBI | |
|
Valapala M, Thamake SI and Vishwanatha JK: A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. J Cell Sci. 124:1453–1464. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma M, Ownbey RT and Sharma MC: Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol. 88:278–286. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gerke V, Creutz CE and Moss SE: Annexins: Linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol. 6:449–461. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ali SM, Geisow MJ and Burgoyne RD: A role for calpactin in calcium-dependent exocytosis in adrenal chromaffin cells. Nature. 340:313–315. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Sarafian T, Pradel LA, Henry JP, Aunis D and Bader MF: The participation of annexin II (calpactin I) in calcium-evoked exocytosis requires protein kinase C. J Cell Biol. 114:1135–1147. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Morel E, Parton RG and Gruenberg J: Annexin A2-dependent polymerization of actin mediates endosome biogenesis. Dev Cell. 16:445–457. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yamada A, Irie K, Hirota T, Ooshio T, Fukuhara A and Takai Y: Involvement of the annexin II-S100A10 complex in the formation of E-cadherin-based adherens junctions in Madin-Darby canine kidney cells. J Biol Chem. 280:6016–6027. 2005. View Article : Google Scholar | |
|
Mai J, Waisman DM and Sloane BF: Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta. 1477:215–230. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Grieve AG, Moss SE and Hayes MJ: Annexin A2 at the interface of actin and membrane dynamics: A focus on its roles in endocytosis and cell polarization. Int J Cell Biol. 2012:8524302012. View Article : Google Scholar : PubMed/NCBI | |
|
Jost M, Zeuschner D, Seemann J, Weber K and Gerke V: Identification and characterization of a novel type of annexin-membrane interaction: Ca2+ is not required for the association of annexin II with early endosomes. J Cell Sci. 110:221–228. 1997. | |
|
König J and Gerke V: Modes of annexin-membrane interactions analyzed by employing chimeric annexin proteins. Biochim Biophys Acta. 1498:174–180. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J and Vishwanatha JK: Regulation of nucleo-cytoplasmic shuttling of human annexin A2: A proposed mechanism. Mol Cell Biochem. 303:211–220. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Jindal HK and Vishwanatha JK: Purification and characterization of primer recognition proteins from HeLa cells. Biochemistry. 29:4767–4773. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Kumble KD and Vishwanatha JK: Immunoelectron microscopic analysis of the intracellular distribution of primer recognition proteins, annexin 2 and phosphoglycerate kinase, in normal and transformed cells. J Cell Sci. 99:751–758. 1991.PubMed/NCBI | |
|
Vishwanatha JK, Jindal HK and Davis RG: The role of primer recognition proteins in DNA replication: Association with nuclear matrix in HeLa cells. J Cell Sci. 101:25–34. 1992.PubMed/NCBI | |
|
Boyko V, Mudrak O, Svetlova M, Negishi Y, Ariga H and Tomilin N: A major cellular substrate for protein kinases, annexin II, is a DNA-binding protein. FEBS Lett. 345:139–142. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Krutilina RI, Babich VS, Kropotov AV, Mudrak OS, Chesnokov IN, Turoverova LV, Konstantinova IM and Tomilin NV: The DNA-binding activity of the membrane protein annexin II and its interaction with antibodies to the chromatin nuclear ribonucleoprotein (alpha-RNP). Tsitologiia. 38:1106–1114. 1996.In Russian. | |
|
Vishwanatha JK and Kumble S: Involvement of annexin II in DNA replication: Evidence from cell-free extracts of Xenopus eggs. J Cell Sci. 105:533–540. 1993.PubMed/NCBI | |
|
Kumble KD, Iversen PL and Vishwanatha JK: The role of primer recognition proteins in DNA replication: Inhibition of cellular proliferation by antisense oligodeoxyribonucleotides. J Cell Sci. 101:35–41. 1992.PubMed/NCBI | |
|
Chiang Y, Rizzino A, Sibenaller ZA, Wold MS and Vishwanatha JK: Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem. 199:139–147. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Madureira PA, Hill R, Lee PW and Waisman DM: Genotoxic agents promote the nuclear accumulation of annexin A2: Role of annexin A2 in mitigating DNA damage. PLoS One. 7:e505912012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CY, Chen CL, Tseng YL, Fang YT, Lin YS, Su WC, Chen CC, Chang KC, Wang YC and Lin CF: Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms. J Biol Chem. 287:32512–32524. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Das S, Shetty P, Valapala M, Dasgupta S, Gryczynski Z and Vishwanatha JK: Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells. Biochemistry. 49:2216–2226. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Frohlich M, Motté P, Galvin K, Takahashi H, Wands J and Ozturk M: Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol. 10:3216–3223. 1990.PubMed/NCBI | |
|
Yang T, Peng H, Wang J, Yang J, Nice EC, Xie K and Huang C: Prognostic and diagnostic significance of annexin A2 in colorectal cancer. Colorectal Dis. 15:e373–e381. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Duncan R, Carpenter B, Main LC, Telfer C and Murray GI: Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer. 98:426–433. 2008. View Article : Google Scholar | |
|
Deng S, Wang J, Hou L, Li J, Chen G, Jing B, Zhang X and Yang Z: Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically. Oncol Lett. 5:107–112. 2013. | |
|
Shetty PK, Thamake SI, Biswas S, Johansson SL and Vishwanatha JK: Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer. PLoS One. 7:e442992012. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP and Sharma MC: Angiogenesis-associated protein annexin II in breast cancer: Selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol. 81:146–156. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chuthapisith S, Bean BE, Cowley G, et al: Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer. 45:1274–1281. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yao H, Zhang Z, Xiao Z, et al: Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer. 65:41–48. 2009. View Article : Google Scholar | |
|
Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, Yan XD and Chen J: Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma. World J Gastroenterol. 18:5897–5904. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Ye Z, Yang Q, He X, Wang H and Zhao Z: Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. World J Surg Oncol. 10:1032012. View Article : Google Scholar : PubMed/NCBI | |
|
Takano S, Togawa A, Yoshitomi H, et al: Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy. Ann Surg Oncol. 15:3157–3168. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yang SF, Hsu HL, Chao TK, Hsiao CJ, Lin YF and Cheng CW: Annexin A2 in renal cell carcinoma: Expression, function, and prognostic significance. Urol Oncol. 33:22.e11–22.e21. 2014. View Article : Google Scholar | |
|
Ma RL, Shen LY and Chen KN: Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma. Oncol Rep. 31:2157–2164. 2014.PubMed/NCBI | |
|
Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K and Tachibana M: Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer. 101:287–294. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Emoto K, Sawada H, Yamada Y, et al: Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res. 21:1339–1345. 2001.PubMed/NCBI | |
|
Liu Z, Ling Q, Wang J, Xie H, Xu X and Zheng S: Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis. Oncol Lett. 6:125–129. 2013.PubMed/NCBI | |
|
Ji NY, Park MY, Kang YH, et al: Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method. Int J Mol Med. 24:765–771. 2009.PubMed/NCBI | |
|
Jeon YR, Kim SY, Lee EJ, Kim YN, Noh DY, Park SY and Moon A: Identification of annexin II as a novel secretory biomarker for breast cancer. Proteomics. 13:3145–3156. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Luo CH, Liu QQ, Zhang PF, Li MY, Chen ZC and Liu YF: Prognostic significance of annexin II expression in non-small cell lung cancer. Clin Transl Oncol. 15:938–946. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Jia JW, Li KL, Wu JX and Guo SL: Clinical significance of annexin II expression in human non-small cell lung cancer. Tumour Biol. 34:1767–1771. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Pei H, Zhu H, Zeng S, et al: Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res. 6:2495–2501. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S and Nakajima Y: Annexin II overexpression correlates with stromal tenascin-C overexpression: A prognostic marker in colorectal carcinoma. Cancer. 92:1419–1426. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kagawa S, Takano S, Yoshitomi H, et al: Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by annexin II in pancreatic cancer cells. J Surg Res. 178:758–767. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Feng JG, Tuersun A, et al: Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang. Mol Biol Rep. 38:3261–3269. 2011. View Article : Google Scholar | |
|
Zhi H, Zhang J, Hu G, Lu J, Wang X, Zhou C, Wu M and Liu Z: The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int J Cancer. 106:327–333. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Pena-Alonso E, Rodrigo JP, Parra IC, Pedrero JM, Meana MV, Nieto CS, Fresno MF, Morgan RO and Fernandez MP: Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma. Cancer Lett. 263:89–98. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tressler RJ, Updyke TV, Yeatman T and Nicolson GL: Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. J Cell Biochem. 53:265–276. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Lokman NA, Elder AS, Ween MP, Pyragius CE, Hoffmann P, Oehler MK and Ricciardelli C: Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget. 4:1199–1211. 2013.PubMed/NCBI | |
|
Shiozawa Y, Havens AM, Jung Y, et al: Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem. 105:370–380. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Myrvang HK, Guo X, Li C and Dekker LV: Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells. FEBS Lett. 587:3210–3215. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kumble KD, Hirota M, Pour PM and Vishwanatha JK: Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. Cancer Res. 52:163–167. 1992.PubMed/NCBI | |
|
Claudio JO, Masih-Khan E, Tang H, et al: A molecular compendium of genes expressed in multiple myeloma. Blood. 100:2175–2186. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YX, Lv H, Li ZX, Li C and Wu XY: Effect of shRNA mediated down-regulation of annexin A2 on biological behavior of human lung adencarcinoma cells A549. Pathol Oncol Res. 18:183–190. 2012. View Article : Google Scholar | |
|
Zhang HJ, Yao DF, Yao M, Huang H, Wang L, Yan MJ, Yan XD, Gu X, Wu W and Lu SL: Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells. World J Gastroenterol. 19:3792–3801. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Guo B, Zhang Y, Cao J and Chen T: Silencing of the annexin II gene down-regulates the levels of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion. Saudi Med J. 31:374–381. 2010.PubMed/NCBI | |
|
Filipenko NR, MacLeod TJ, Yoon CS and Waisman DM: Annexin A2 is a novel RNA-binding protein. J Biol Chem. 279:8723–8731. 2004. View Article : Google Scholar | |
|
Mickleburgh I, Burtle B, Hollås H, Campbell G, Chrzanowska-Lightowlers Z, Vedeler A and Hesketh J: Annexin A2 binds to the localization signal in the 3′ untranslated region of c-myc mRNA. FEBS J. 272:413–421. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Hollås H, Aukrust I, Grimmer S, Strand E, Flatmark T and Vedeler A: Annexin A2 recognises a specific region in the 3′-UTR of its cognate messenger RNA. Biochim Biophys Acta. 1763:1325–1334. 2006. View Article : Google Scholar | |
|
Pelengaris S and Khan M: The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets. 7:623–642. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Huang Y, Jin Y, Yan CH, Yu Y, Bai J, Chen F, Zhao YZ and Fu SB: Involvement of annexin A2 in p53 induced apoptosis in lung cancer. Mol Cell Biochem. 309:117–123. 2008. View Article : Google Scholar | |
|
Rengifo-Cam W, Umar S, Sarkar S and Singh P: Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-κB. Cancer Res. 67:7266–7274. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sarkar S, Swiercz R, Kantara C, Hajjar KA and Singh P: Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells. Gastroenterology. 140:583.e4–595.e4. 2011. View Article : Google Scholar | |
|
Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI | |
|
Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Carmeliet P: Angiogenesis in health and disease. Nat Med. 9:653–660. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Risau W: Mechanisms of angiogenesis. Nature. 386:671–674. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Bergers G and Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lima e Silva R, Shen J, Gong YY, Seidel CP, Hackett SF, Kesavan K, Jacoby DB and Campochiaro PA: Agents that bind annexin A2 suppress ocular neovascularization. J Cell Physiol. 225:855–864. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma M, Blackman MR and Sharma MC: Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model. Exp Mol Pathol. 92:175–184. 2012. View Article : Google Scholar | |
|
Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med. 6:389–395. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao S, Huang L, Wu J, Zhang Y, Pan D and Liu X: Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy. Mol Vis. 15:1231–1242. 2009.PubMed/NCBI | |
|
Raddum AM, Evensen L, Hollås H, Grindheim AK, Lorens JB and Vedeler A: Domains I and IV of annexin A2 affect the formation and integrity of in vitro capillary-like networks. PLoS One. 8:e602812013. View Article : Google Scholar : PubMed/NCBI | |
|
Dejana E, Orsenigo F and Lampugnani MG: The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci. 121:2115–2122. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Su SC, Maxwell SA and Bayless KJ: Annexin 2 regulates endothelial morphogenesis by controlling AKT activation and junctional integrity. J Biol Chem. 285:40624–40634. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sun XT, Yuan XW, Zhu HT, Deng ZM, Yu DC, Zhou X and Ding YT: Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma. World J Gastroenterol. 18:4925–4933. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yu DC, Chen J, Sun XT, Zhuang LY, Jiang CP and Ding YT: Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer. 10:4352010. View Article : Google Scholar : PubMed/NCBI | |
|
Finney MR, Greco NJ, Haynesworth SE, et al: Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol Blood Marrow Transplant. 12:585–593. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pollard TD and Borisy GG: Cellular motility driven by assembly and disassembly of actin filaments. Cell. 112:453–465. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Revenu C, Athman R, Robine S and Louvard D: The co-workers of actin filaments: From cell structures to signals. Nat Rev Mol Cell Biol. 5:635–646. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wei J, Liu Y, Chang M, Sun CL, Li DW, Liu ZQ and Hu LS: Proteomic analysis of oxidative modification in endothelial colony-forming cells treated by hydrogen peroxide. Int J Mol Med. 29:1099–1105. 2012.PubMed/NCBI | |
|
Zhang X, Cui X, Cheng L, Guan X, Li H, Li X and Cheng M: Actin stabilization by jasplakinolide affects the function of bone marrow-derived late endothelial progenitor cells. PLoS One. 7:e508992012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Zhang L, Zhang B, Wei X, Yang Y, Qi RZ, Ying G, Zhang N and Niu R: Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. J Proteome Res. 8:5041–5047. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wu W, Tang X, Hu W, Lotan R, Hong WK and Mao L: Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis. 19:319–326. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Maruo T, Ichikawa T, Kanzaki H, et al: Proteomics-based analysis of invasion-related proteins in malignant gliomas. Neuropathology. 33:264–275. 2013. View Article : Google Scholar | |
|
Tatenhorst L, Rescher U, Gerke V and Paulus W: Knockdown of annexin 2 decreases migration of human glioma cells in vitro. Neuropathol Appl Neurobiol. 32:271–277. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mignatti P and Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 73:161–195. 1993.PubMed/NCBI | |
|
McColl BK, Baldwin ME, Roufail S, Freeman C, Moritz RL, Simpson RJ, Alitalo K, Stacker SA and Achen MG: Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med. 198:863–868. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Bajou K, Masson V, Gerard RD, et al: The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol. 152:777–784. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Díaz VM, Planaguma J, Thomson TM, Reventós J and Paciucci R: Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells. Gastroenterology. 122:806–819. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Pepper MS: Extracellular proteolysis and angiogenesis. Thromb Haemost. 86:346–355. 2001.PubMed/NCBI | |
|
Tarui T, Majumdar M, Miles LA, Ruf W and Takada Y: Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem. 277:33564–33570. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ranson M and Andronicos NM: Plasminogen binding and cancer: Promises and pitfalls. Front Biosci. 8:s294–s304. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Wu B, Zhang F, Yu M, Zhao P, Ji W, Zhang H, Han J and Niu R: Up-regulation of Anxa2 gene promotes proliferation and invasion of breast cancer MCF-7 cells. Cell Prolif. 45:189–198. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Zhao P, Xu XL, Cai L, Song ZS, Cao DY, Tao KS, Zhou WP, Chen ZN and Dou KF: Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells. PLoS One. 8:e672682013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li Y, Jiang JL, Zhang SH and Chen ZN: Annexin II promotes invasion and migration of human hepatocellular carcinoma cells in vitro via its interaction with HAb18G/CD147. Cancer Sci. 101:387–395. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nedjadi T, Kitteringham N, Campbell F, Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos JP and Costello E: S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br J Cancer. 101:1145–1154. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002. View Article : Google Scholar : PubMed/NCBI |
